ARX-positive insulinomas show genetic alterations also seen in non-functioning pNETs, such as loss of ATRX/DAXX and CDKN2A. It has been suggested that atypical insulinomas most likely exist as non-functioning pNETs for a time before becoming clinically functioning (41). The gene discussed is CDKN2A; the disease is pancreatic insulinoma.